Melinda Tan Si Yun

Real-World Experience of Measurable Residual Disease Response and Prognosis in Acute Myeloid Leukemia Treated with Venetoclax and Azacitidine

M. Ooi, H. Ng, S. Ong, 2022, Cancers.